The Emerging Role of MicroRNAs in Breast Cancer

Abstract EN

Breast cancer (BC) is the most common malignancy in women.

Due to BC heterogeneity, complexity, and metastasis, many BC patients do not successfully respond to therapies.

The effective management of BC depends on early diagnosis and monitoring of drug response.

Therefore, identifying new biomarkers for the diagnosis, prognosis, and development of new drugs is urgently required.

Dysregulation of microRNAs (miRNAs) participates in the tumorigenesis and progression of cancers, especially breast cancer (BC).

Several studies demonstrated that miRNAs could perform their function as oncogenes or tumor suppressors.

This review describes recent progress on the role of microRNAs in the diagnosis, prognosis, hallmark, and treatment of BC.

According to a recent literature survey, miRNAs play a pivotal role in the regulation of hallmarks of cancer, such as proliferation, apoptosis, invasion, metastasis, and tumor stemness.

Many miRNAs are potential biomarkers for BC for diagnosis, and some are indicators of prognosis.

Moreover, circulating miRNA profiles, as minimally invasive, diagnostic, and prognostic markers, are broadly used in BC therapy, and some miRNAs are good predictors of therapeutic outcomes.

Other miRNAs are involved in overcoming chemoresistance and in increasing BC drug sensitivity.